Company

Neovasc Inc.

Headquarters: Richmond, BC, Canada

Employees: 49

CEO: Mr. Fredericus A. Colen

TSX: NVCN

Market Cap

C$111.8 Million

CAD as of April 1, 2023

US$84.4 Million

Market Cap History

Neovasc Inc. market capitalization over time

Evolution of Neovasc Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Neovasc Inc.

Detailed Description

Neovasc Inc., a specialty medical device company, develops, manufactures, and markets medical devices for cardiovascular marketplace in Europe, Canada, the United States, and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Neovasc Inc. has the following listings and related stock indices.


Stock: TSX: NVCN wb_incandescent

Stock: NASDAQ: NVCN wb_incandescent

Stock: FSX: G5Z3 wb_incandescent

Details

Headquarters:

13562 Maycrest Way

Suite 5138

Richmond, BC V6V 2J7

Canada

Phone: 604 270 4344

Fax: 604 270 4384